REGENCELL BIOSCIENCE HOLDING (RGC) Stock Price & Overview

NASDAQ:RGC • KYG7487R1002

24.02 USD
-1.43 (-5.62%)
Last: Mar 5, 2026, 02:23 PM

The current stock price of RGC is 24.02 USD. Today RGC is down by -5.62%. In the past month the price decreased by -10.54%. In the past year, price increased by 23430.4%.

RGC Key Statistics

52-Week Range0.105 - 83.6
Current RGC stock price positioned within its 52-week range.
1-Month Range22.23 - 35.7
Current RGC stock price positioned within its 1-month range.
Market Cap
11.878B
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
N/A
Dividend Yield
N/A

RGC Stock Performance

Today
-5.62%
1 Week
-4.00%
1 Month
-10.54%
3 Months
+56.71%
Longer-term
6 Months +91.93%
1 Year +23,430.40%
2 Years +21,391.10%
3 Years +3,636.86%
5 Years N/A
10 Years N/A

RGC Stock Chart

REGENCELL BIOSCIENCE HOLDING / RGC Daily stock chart

RGC Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to RGC. When comparing the yearly performance of all stocks, RGC is one of the better performing stocks in the market, outperforming 100% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
RGC Full Technical Analysis Report

RGC Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to RGC. No worries on liquidiy or solvency for RGC as it has an excellent financial health rating, but there are worries on the profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
RGC Full Fundamental Analysis Report

RGC Earnings

Next Earnings DateN/A
Last Earnings DateOct 23, 2025
PeriodQ2 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %
RGC Earnings History

RGC Forecast & Estimates


Analysts
Analysts63.4
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
RGC Forecast & Estimates

RGC Groups

Sector & Classification

RGC Financial Highlights


Income Statements
Revenue(TTM)N/A
Net Income(TTM)-4.09M
Industry RankSector Rank
PM (TTM) N/A
ROA -54.68%
ROE -60.86%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)100%
Revenue 1Y (TTM)N/A
RGC financials

RGC Ownership

Ownership
Inst Owners0.13%
Shares494.49M
Float56.59M
Ins Owners88.56%
Short Float %1.19%
Short Ratio1.28
RGC Ownership

RGC Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
LLY ELI LILLY & CO28.94948.755B
JNJ JOHNSON & JOHNSON20.38591.001B
MRK MERCK & CO. INC.21.36298.537B
PFE PFIZER INC8.81151.354B
BMY BRISTOL-MYERS SQUIBB CO9.97126.888B
ZTS ZOETIS INC17.8755.509B
RPRX ROYALTY PHARMA PLC- CL A8.7327.378B
VTRS VIATRIS INC5.7716.937B
ELAN ELANCO ANIMAL HEALTH INC22.5212.151B
AXSM AXSOME THERAPEUTICS INC N/A8.393B
BLTE BELITE BIO INC - ADR N/A6.67B
TERN TERNS PHARMACEUTICALS INC N/A4.517B
GPCR STRUCTURE THERAPEUTICS INC N/A4.459B

About RGC

Company Profile

RGC logo image Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company employs 12 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.

Company Info

REGENCELL BIOSCIENCE HOLDING

11/F, First Commercial Building, 33-35 Leighton Road, Causeway Bay

Hong Kong 37918 HK

CEO: Yat-Gai Au

Employees: 12

RGC Company Website

RGC Investor Relations

Phone: 85221550823

REGENCELL BIOSCIENCE HOLDING / RGC FAQ

What does RGC do?

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company employs 12 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.


What is the current price of RGC stock?

The current stock price of RGC is 24.02 USD. The price decreased by -5.62% in the last trading session.


Does RGC stock pay dividends?

RGC does not pay a dividend.


What is the ChartMill rating of REGENCELL BIOSCIENCE HOLDING stock?

RGC has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Which stock exchange lists RGC stock?

RGC stock is listed on the Nasdaq exchange.


Can you provide the sector and industry classification for REGENCELL BIOSCIENCE HOLDING?

REGENCELL BIOSCIENCE HOLDING (RGC) operates in the Health Care sector and the Pharmaceuticals industry.